Search

Search results

1498 results found

Determination of Minimal Clinically Important Change in Early and Advanced Parkinson's Disease. Mov Disord 2011;26:813-8.

Publication: Journal Article

Hauser, RA, P Auinger, and Parkinson Study Group. 2012. “Determination of Minimal Clinically Important Change in Early and Advanced Parkinson’s Disease. Mov Disord 2011;26:813-8.”. Mov Disord.

Linh Hoang

Person: Undergrad Student

Linh Hoang is a junior undergraduate student at the University of South Florida, majoring in Biomedical Sciences with a strong passion for Neuroscience. She is eager to explore the intricacies of the nervous system and is particularly interested in studying the biophysical properties of neurons in...

Multiunit Frontal Eye Field Activity Codes the Visuomotor Transformation, But Not Gaze Prediction or Retrospective Target Memory, in a Delayed Saccade Task

Publication: Journal Article

Seo, Serah, Vishal Bharmauria, Adrian Schütz, Xiaogang Yan, Hongying Wang, and John Douglas Crawford. 2024. “Multiunit Frontal Eye Field Activity Codes the Visuomotor Transformation, But Not Gaze Prediction or Retrospective Target Memory, in a Delayed Saccade Task”. ENeuro.

Clinico-physiological correlates of Parkinson’s disease from multi-resolution basal ganglia recordings

Publication: Journal Article

Sumarac, Srdjan, Jinyoung Youn, Conor Fearon, Luka Zivkovic, Prerana Keerthi, Oliver Flouty, Milos Popovic, et al. 2024. “Clinico-Physiological Correlates of Parkinson’s Disease from Multi-Resolution Basal Ganglia Recordings”. Npj Parkinson’s Disease.

Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trial

Publication: Journal Article

Poewe, W, O Rascol, P Barone, RA Hauser, Y Mizuno, M Haaksma, L Salin, N Juhel, and AH Shapira. 2011. “Extended-Release Pramipexole in Early Parkinson Disease: A 33-Week Randomized Controlled Trial”. Neurology.

Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects

Publication: Journal Article

Lyons, KE, JH Friedman, N Hermanowicz, SH Isaacson, RA Hauser, BP Hersh, DE Silver, et al. 2010. “Orally Disintegrating Selegiline in Parkinson Patients With Dopamine Agonist-Related Adverse Effects”. Clin Neuropharmacol.

Early pharmacologic treatment in Parkinson's disease

Publication: Journal Article

Hauser, RA. 2010. “Early Pharmacologic Treatment in Parkinson’s Disease”. Am J Manag Care.

Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease

Publication: Journal Article

Bronzova, J, C Sampaio, RA Hauser, AE Lang, O Rascol, A Theeuwes, SV Van De Witte, and G van Scharrenburg. 2010. “Double-Blind Study of Pardoprunox, a New Partial Dopamine Agonist, in Early Parkinson’s Disease”. Mov Disord.

Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease

Publication: Journal Article

Watts, RL, KE Lyons, R Pahwa, K Sethi, M Stern, RA Hauser, W Olanow, AM Gray, B Adams, and NL Earl. 2010. “Onset of Dyskinesia With Adjunct Ropinirole Prolonged-Release or Additional Levodopa in Early Parkinson’s Disease”. Mov Disord.

Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease

Publication: Journal Article

Hauser, RA, KE Lyons, T McClain, S Carter, and D Perlmutter. 2009. “Randomized, Double-Blind, Pilot Evaluation of Intravenous Glutathione in Parkinson’s Disease”. Mov Disord.